Avanos Medical, Inc.
AVNSNYSEHealthcare● Active
$25.00
$-0.05(-0.20%)
Market Cap$1.2B
P/E Ratio—
52W High$25.49
52W Low$9.303
Avanos Medical, Inc. (AVNS) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · AVNS · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($0.07B) | ($0.39B) | ($0.06B) | $0.05B | $0.01B |
| Depreciation & Amort. | $0.04B | $0.05B | $0.05B | $0.05B | $0.04B |
| Stock-Based Comp. | $0.00B | $0.01B | $0.02B | $0.02B | $0.01B |
| Change in Working Capital | $0.01B | $0.04B | ($0.02B) | ($0.02B) | $0.03B |
| Net Cash from Operations | $0.07B | $0.10B | $0.03B | $0.09B | $0.09B |
| Investing Activities | |||||
| Capital Expenditure | ($0.03B) | ($0.02B) | ($0.02B) | ($0.02B) | ($0.02B) |
| Purchases of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Sales of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Investing | ($0.06B) | ($0.03B) | $0.02B | ($0.14B) | ($0.02B) |
| Financing Activities | |||||
| Common Stock Repurchased | ($0.00B) | ($0.01B) | ($0.02B) | ($0.05B) | ($0.01B) |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | ($0.03B) | ($0.03B) | ($0.06B) | $0.10B | ($0.05B) |
| Net Cash from Financing | ($0.04B) | ($0.05B) | ($0.09B) | $0.06B | ($0.06B) |
| Free Cash Flow | |||||
| Free Cash Flow | $0.04B | $0.08B | $0.01B | $0.07B | $0.07B |
| FCF Margin %(computed) | 6.15% | 12.05% | 2.17% | 10.47% | 8.90% |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more Avanos Medical, Inc. data
About Avanos Medical, Inc. (AVNS) Cash Flow Statement
Avanos Medical, Inc. generated operating cash flow of $0.07B and free cash flow of $0.04B for 2025 — a FCF margin of 6.15%. Capital expenditure was ($0.03B).
Frequently asked questions
AVNS · 4 questionsAvanos Medical, Inc. generated free cash flow of $0.04B for 2025, down 48.0% year-over-year.
AVNS free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10